Ariel Raskin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Candida Albicans

Top Venues

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Manuel Carreño, Abram Luther Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana Silvia Gonzalez-Reiche, Johnstone Tcheou, Ariel Raskin, Dominika Bielak, Sara Morris, Miriam Fried, Temima Yellin, Leeba Sullivan, null null, Emilia Mia Sordillo, Aubree Gordon, Harm van Bakel, Viviana Simon, Florian Krammer
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023. Nature communications 15 (1) (2024)
Juan Manuel Carreño, Abram Luther Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana Silvia Gonzalez-Reiche, Johnstone Tcheou, Ariel Raskin, Dominika Bielak, Sara Morris, Miriam Fried, Temima Yellin, Leeba Sullivan, null null, Emilia Mia Sordillo, Aubree Gordon, Harm van Bakel, Viviana Simon, Florian Krammer
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023. Nature communications 15 (1) (2024)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)